Are Markers of Cardiac Dysfunction Useful in the Assessment of Cardiovascular Risk in Dialysis Patients?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current pharmaceutical design

• Publication date

  2017-05-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1381612823666170508152501PMID 28486916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating heart-type fatty acid-binding protein levels predict ventricular fibrillation in Brugada syndrome.

  2016cited by this paper
• Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

  2016cited by this paper
• The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism

  2016cited by this paper
• The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease.

  2016cited by this paper
• Copeptin: Pathophysiology and potential clinical impact.

  2015cited by this paper
• Sudden cardiac death in CKD patients

  2015cited by this paper
• Intradialytic hypotension and risk of cardiovascular disease.

  2014cited by this paper
• Heart function disturbances in chronic kidney disease – echocardiographic indices

  2014cited by this paper
• The Sympathetic Nervous System in Chronic Kidney Disease

  2013cited by this paper
• Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain.

  2013cited by this paper
• Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients.

  2013cited by this paper
• Copeptin and its potential role in diagnosis and prognosis of various diseases

  2013cited by this paper
• Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction.

  2012cited by this paper
• Factors associated with intradialytic systolic blood pressure variability.

  2012cited by this paper
• Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverter-defibrillators.

  2012cited by this paper
• Copeptin (C-terminal provasopressin): a promising marker of arrhythmogenesis in arrhythmia prone subjects?

  2011cited by this paper
• Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.

  2011cited by this paper
• Changes in QT intervals in patients with end-stage renal disease before and after hemodialysis.

  2010cited by this paper
• Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.

  2010cited by this paper
• The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism

  2010cited by this paper
• Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease: Results From the AtheroGene Study

  2009cited by this paper
• Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease.

  2009cited by this paper
• Fluid Retention Is Associated With Cardiovascular Mortality in Patients Undergoing Long-Term Hemodialysis

  2009cited by this paper
• Growth Differentiation Factor-15: a New Biomarker in Cardiovascular Disease

  2009cited by this paper
• Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.

  2009cited by this paper
• Hemodialysis-induced cardiac injury: determinants and associated outcomes.

  2009cited by this paper
• Incremental value of copeptin for rapid rule out of acute myocardial infarction.

  2009cited by this paper
• Recent advances in the prevention and management of intradialytic hypotension.

  2008cited by this paper
• The challenge of sudden death in dialysis patients.

  2008cited by this paper
• Gene Expression Pattern in Biomechanically Stretched Cardiomyocytes: Evidence for a Stretch-Specific Gene Program

  2008cited by this paper
• Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction.

  2007cited by this paper
• The Acute Cardiac Effects of Dialysis

  2007cited by this paper
• Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome

  2007cited by this paper
• Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction.

  2007cited by this paper
• Characteristics of sudden death in hemodialysis patients.

  2006cited by this paper
• Minimized Weight Gain between Hemodialysis Contributes to a Reduced Risk of Death

  2006cited by this paper
• Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer.

  2006cited by this paper
• Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.

  2006cited by this paper
• Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage.

  2006cited by this paper
• The Transforming Growth Factor-&bgr; Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury

  2006cited by this paper
• Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes

  2006cited by this paper
• Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis

  2005cited by this paper
• Electrocardiographic abnormalities and uremic cardiomyopathy.

  2005cited by this paper
• Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences.

  2004cited by this paper
• Relationship between volume status and blood pressure during chronic hemodialysis.

  2002cited by this paper
• Ventricular Arrhythmias and Sudden Cardiac Death in End-Stage Renal Disease Patients on Chronic Hemodialysis

  2001cited by this paper
• The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group

  1999cited by this paper
• Sudden and cardiac death rates in hemodialysis patients.

  1999cited by this paper
• MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.

  1997cited by this paper
• Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure.

  1997cited by this paper

• Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.

  2019cites this paper
• GDF-15: A Multifunctional Modulator and Potential Therapeutic Target in Cancer.

  2019cites this paper
• Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients

  2018cites this paper
• Modern peptide biomarkers and echocardiography in cardiac healthy haemodialysis patients

  2017cites this paper